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Background: This study investigated the hypothesis that long-term orange juice consumption (≥ 12 months) was
associated with low risk factors for cardiovascular disease in adult men and women with normal and moderately
high cholesterol blood levels.
Methods: The sample consisted of 103 men (18–66 y) and 26 women (18–65 y); all were employees of an orange
juice factory with daily access to free orange juice. The results showed that 41% of the individuals consumed 2
cups (480 mL) of orange juice per day for at least twelve months, while 59% of the volunteers are non-consumers
of orange juice.
Results: Orange juice consumers with normal serum lipid levels had significantly lower total cholesterol
(−11%, p <0.001), LDL-cholesterol (−18%, p < 0.001), apolipoprotein B (apo B) (−12%, p < 0.01) and
LDL/HDL ratio (−12%, p < 0.04) in comparison to non-consumers, as did the consumers with moderate
hypercholesterolemia: lower total cholesterol (−5%, p <0.02), LDL-cholesterol (−12%, p <0.03),
apolipoprotein B (−12%, p <0.01) and LDL/HDL ratio (−16%, p <0.05) in comparison the non-consumers
counterparts. Serum levels of homocysteine, HDL- cholesterol and apolipoprotein A-1, body
composition and the dietary intake of food energy and macronutrients did not differ among orange
juice consumers and non-consumers, but vitamin C and folate intake was higher in orange juice
consumers.
Conclusion: Long-term orange juice consumers had lower levels of total cholesterol, LDL-cholesterol,
apo B and LDL/HDL ratio and an improvement of folate and vitamin C in their diet.
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Introdução: O presente estudo investigou a hipótese de que o consumo de suco de laranja a longo prazo
(≥ 12 meses) foi associado com menor fator de risco para doença cardiovascular em homens e mulheres adultos
com nível normal e moderadamente alto de colesterol no sangue.
Métodos: A amostra foi composta por 103 homens (18–66 anos) e 26 mulheres (18–65 anos) todos eram
funcionários de uma fábrica de suco de laranja com acesso diário e gratuito ao suco de laranja. Os resultados
mostraram que 41% dos indivíduos consumiram dois copos (480 mL) de suco de laranja por dia durante pelo
menos 12 meses, enquanto 59% dos voluntários não eram consumidores de suco de laranja.
Resultados: Os consumidores de suco de laranja com níveis normais de lipídeos séricos apresentaram menor teor
de colesterol total (−11% p < 0.001), LDL-colesterol (−18%, p <0.001), apolipoproteína B (apo B) (−12%, p <0.01)
e LDL/HDL (−12%, p <0.04) em comparação com os não-consumidores; assim como os consumidores com
hipercolesterolemia moderada (−5% p <0.02), LDL-colesterol (−12%, p <0.03), apolipoproteína B (−12%, p <0.01)
e LDL/HDL (−16%, p <0.05) em comparação aos seus pares de não-consumidores. Os níveis séricos de homocisteína,
HDL-colesterol e apolipoproteína A-1, a composição corporal e a ingestão de energia e de macronutrientes da dieta
não diferiram entre os consumidores de suco de laranja e não-consumidores, mas a vitamina C e o folato estavam
mais elevados na dieta nos consumidores de suco de laranja.
Conclusão: Os consumidores de suco de laranja de longo prazo apresentaram menores níveis de colesterol total,
LDL-colesterol, apo B e razão LDL/HDL e uma melhoria nos níveis de folato e vitamina C nas suas dietas.
Palavras-chave: Suco de laranja LDL-colesterol, Apo B, Homocisteína, HumanosBackground
Consumption of fruits and vegetables is associated with
a lower risk of coronary artery disease and this effect is
attributed mainly to the functional and antioxidant
actions of vitamins and phytochemicals, such as phenolic
compounds and flavonoids [1-5]. In developed countries,
foods such as wine, grapes and tea provide the greatest
proportion of dietary flavonoids, followed by citrus fruits
and orange juice [6]. Non-starchy vegetables and fruits,
such as lettuce, tomatoes, onions and citrus provide 60 to
106 mg of flavonoids per day to the Brazilian diet, and
oranges and fresh squeezed orange juice are responsible
for more than 70% of the total flavonoid intake [7].
Orange juice contains considerable amounts of flavo-
noids, mainly hesperidin, and its content is related to
juice processing conditions. Experimental studies have
shown that hesperidin has anti-inflammatory, antiallergic,
hypolipidemic and anticarcinogenic properties [7-12]. These
flavonoids help to lower serum levels of LDL-cholesterol
[13-15] and apo B [16,17], and can reduce triglycerides [16]
and increase HDL-cholesterol [18], reducing risk of
coronary artery disease [10,19,20]. The antioxidant effect of
vitamin C is vasoprotective [20,21] and even small amounts
of folate have been associated with lower homocysteine
levels and less thromboembolic events [22].
Dyslipidemias are the main risk factors for the devel-
opment of atherosclerosis, followed by visceral fat and
obesity, which are related to higher rates of morbidity
and mortality from coronary artery disease [23]. Lower
total and LDL-cholesterol levels have been associated
with decreased risk of coronary artery disease andrelated conditions, and thus vegetable-based diets are
recommended for the treatment of dyslipidemias, not
only because of low saturated fat and cholesterol, but also
because of the significant amounts of micronutrients
and bioactive compounds [24-26].
The actions of citrus flavonoids have been investigated
in clinical and experimental studies, but most studies
used high doses of isolated forms of these compounds,
such as hesperidin or naringin [5,16,27]. Clinical studies
with normolipidemic and hypercholesterolemic subjects
committed to a regular consumption of orange juice
have shown decreased LDL-cholesterol levels [13,14] and
increased HDL-cholesterol levels [18]. However, these
effects were not yet investigated in subjects with non-
controlled long-term daily orange juice consumption.
The present cross-sectional study investigated the
hypothesis that a daily long-term consumption of orange
juice is associated with an improvement of lipid profile and
as such, helps to lower the risk factors of cardiovascular
disease in normolipidemic and moderately hypercholester-
olemic adults. To test this hypothesis we compared bio-
chemical, anthropometric and dietary parameters of regular
consumers and non-consumers of commercially processed
orange juice. To avoid external influences, none of
the subjects were under cholesterol-lowering medication.
Results
All women (n = 36) and 62% of the men (n = 64) had normal
serum cholesterol levels (total cholesterol < 6.2 mmol/L) and
38% of the men (n = 39) had moderately high serum
cholesterol levels (total cholesterol ≥ 6.2 mmol/L). The
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and gender to study the anthropometric and dietary
variables and only by total serum cholesterol to study
the biochemical variables.
Nutritional assessment of the men and women with
normal and men with high total cholesterol levels, grouped
according to orange juice consumption, revealed no
differences among the groups regarding daily intake
of food energy, protein, carbohydrate, dietary fiber,
total fruit, total fat, saturated fat, cholesterol and potassium
(p > 0.05) (Table 1). However, vitamin C and folate intakes,
calculated from the 24-hour recall, were greater in
individuals who consumed orange juice regularly than
in those who did not, regardless of group (p ≤ 0.05)
(Table 1). The mean orange juice intake of regular
consumers, regardless of gender, was 480 ± 158 mL/d,
ranging from 240 to 720 mL/d. In women, the mean
orange juice intake was 390 ± 149 mL/d, representing
7.9% of the total dietary energy and 14.6% of the total
dietary carbohydrate. In men, regardless of cholesterol
level, the mean orange juice intake was 476 ± 158 mL/d,
representing 7.8% of the total dietary energy and 15.3% of
the total dietary carbohydrate. Therefore, the percentage
energy and carbohydrate intakes from orange juice for
men and women were very similar (Table 1).
Among women, 68% had a normal BMI and 32%





Orange juice Non-consumers Consumers Non-c
mL/d 0 390 ± 149
MJ/d 0 0.74 ±0.28
Total Energy(MJ/d) 8.01 ± 2.02 9.44 ±2.25 11.
Protein (g/d) 83.1 ± 28.4 112 ± 38.7 117
Carbohydrate (g/d) 233 ± 97.3 307 ± 104 32
Dietary fiber (g/d) 12.0 ± 6.8 14.7 ± 10.0 23.
Total fruits (g/d) 93 ± 95 89 ± 114 13
Total fat (g/d) 61.5 ± 22.1 62.2 ± 10.6 94.
Saturated fats (g/d) 19.3 ± 9.37 18.9 ± 4.79 30.1
Cholesterol (mg/d) 211 ± 137 317 ± 62.4 31
Vitamin C (mg/d) 107 ± 108 221 ± 252* 13
Folate (μg/d) 211 ± 108 307 ± 140* 39
Potassium (g/d) 3.5± 1.2 3.8±1.7 3.
Data are expressed as means ± SD.
Statistical comparison (test t) was between non-consumers and consumers groups of n
*p < 0.05.
# Normolipidemic: total cholesterol < 6.2 mmol/L.
##Hypercholesterolemic: total cholesterol ≥ 6.2 mmol/L.men were normal weight and 58% were overweight and
obese (80 and 20% respectively). These results suggested
that a large percentage of the participants in this investiga-
tion were overweight; that is, 32% of the women and 58%
of the men. Comparison of the anthropometric variables of
all groups with normal and high cholesterol levels showed
that regular orange juice consumption was not associated
with body weight, BMI, waist circumference or percentage
of body fat (p > 0.05) (Table 2). Hypercholesterolemia
was present in 38% of the men, especially in those
with excessive weight and increased waist circumference,
while normocholesterolemic women and men showed an
average BMI within normal range.
The comparison of physical activity levels between
orange juice consumers and non-consumers (Table 2)
showed no statistical differences (p > 0.05). In fact, the
average physical activity coefficient (PA) ranged from
1.11 to 1.18, meaning low physical activity for both
genders, among consumers and non-consumers, according
to DRI-2005 [28]. The percentage of volunteers with
sedentary or low active life style was higher (≥ 55%)
than the active subjects in all groups (≤ 45%). Very active
subjects were only detected among normolipidemic men,
in very low proportion (3%).
Biochemical data of men and women with normal
cholesterol levels and men with high cholesterol levels
are presented in Table 3. Normolipidemic individualsonsumers according to gender and serum
Hypercholesterolemic##
Men Men
38 26 23 16
onsumers Consumers Non-consumers Consumers
0 466 ± 163 0 486 ± 145
0 0.89 ±0.30 0 0.92 ± 0.27
5 ± 5.04 11.6 ±2.51 12.0 ± 2.88 11.8 ± 2.0
± 20.1 125 ± 28.4 132 ± 33.6 143 ± 25.8
7 ± 111 346 ± 113 382 ± 123 367 ± 72.3
5 ± 12.2 25.2 ± 14.0 27.0 ± 14.0 23.4 ± 11.6
8 ± 184 94 ± 149 157 ± 197 125 ± 138
5 ± 32.4 98.6 ± 28.2 90.3 ± 37.8 90.6 ± 27.4
± 12.35 31.3 ± 10.3 27.8 ± 10.2 29.3 ± 12.8
6 ± 113 345 ± 109 317 ± 116 345 ± 123
8 ± 115 227 ± 121* 174 ± 120 273 ± 158*
3 ± 138 500 ± 148* 423 ± 146 538 ± 166*
6 ± 1.0 4.2 ± 1.1* 4.2 ± 1.2 4.2 ± 0.9
ormolipidemic women, normolipidemic men, and hypercholesterolemic men
Table 2 Anthropometric and physical activity parameters of orange juice consumers and non-consumers according to
gender and serum cholesterol level
Normolipidemic Hypercholesterolemic
Subjects Women Men Men
n 18 8 38 26 23 16
Orange juice Non-consumers Consumers Non-consumers Consumers Non-consumers Consumers
mL/d 0 390 ± 149 0 466 ± 163 0 486 ± 145
Age (years) 37.6 ± 10.2 39.2 ± 12.2 36.8 ± 9.92 33.8 ± 10.9 41.9 ± 9.8 40.8 ± 8.0
Weight (kg) 64.0 ± 12.4 63.2 ±10.6 75.9 ± 11.4 70.8 ±10.0 78.5 ±13.8 83.0 ± 10.5
BMI (kg/m2) 24.5 ± 4.36 24.6 ±4.99 25.1 ± 3.63 23.8 ±2.89 26.6 ± 2.8 27.0 ± 3.4
Body fat (%) 36.7 ± 4.45 33.9 ± 6.53 27.8 ± 5.03 25.1 ± 7.52 28.0 ± 5.7 27.0 ± 4.1
Waist circ.(cm) 82.5 ±10.5 88.5 ± 12.3 90.4 ±9.96 87.5 ± 9.33 96.3 ± 8.2 97.5 ± 9.3
Physical Activity
PA### 1.11 ± 0.11 1.16 ± 0.13 1.17 ± 0.11 1.15 ± 0.10 1.18 ± 0.08 1.17 ± 0.11
Duration (h/d) 0.66 ± 0.61 0.50 ± 0.44 1.18 ± 1.23 1.06 ± 0.79 0.89 ± 0.48 0.80 ± 0.64
Frequency (times/wk) 2.39 ± 2.59 3.38 ± 2.83 2.94 ± 2.37 2.75 ± 2.27 2.72 ± 1.74 3.23 ± 2.17
Sedentary#### (%) 56 38 16 15 5 29
Low Active (%) 11 38 37 46 50 31
Active (%) 33 25 45 38 45 40
Very Active (%) 0 0 3 0 0 0
Data are expressed as means ± SD.
Statistical comparison (test t) was between non-consumers and consumers groups of normolipidemic women and men, and hypercholesterolemic men.
*p < 0.05.
# Normolipidemic: total cholesterol < 6.2 mmol/L.
##Hypercholesterolemic: total cholesterol ≥ 6.2 mmol/L.
### PA is the physical activity coefficient according to DRI (2005).
#### % individuals with Sedentary, Low Active, Active or Very Active life style.
Table 3 Biochemical characteristics of orange juice consumers and non-consumers according to gender and serum
cholesterol level
Normolipidemic Hypercholesterolemic
n 56 34 23 16
Orange juice Non-consumers Consumers Non-consumers Consumers
mL/d 0 530 ± 188 0 486 ± 145
Triacylglycerol (mmol/L) 1.15 ±0.37 1.11 ±0.55 1.86 ± 0.63 2.16 ±1.12
Cholesterol (mmol/L)
Total 5.08 ±0.70 4.54 ±0.78* 6.77 ± 0.41 6.40 ±0.58*
HDL 1.20 ±0.29 1.16 ±0.31 1.14 ± 0.27 1.16 ± 0.23
LDL 3.35 ±0.61 2.74 ±0.80* 4.78 ± 0.48 4.20 ± 0.86*
LDL/HDL ratio 2.93±0.86 2.57 ±2.57* 4.46 ± 1.25 3.73 ±1.00*
Apolipoprotein (g/L)
A-I 1.40 ±0.25 1.36 ±0.25 1.41 ± 0.28 1.39 ± 0.18
B 0.90 ±0.19 0.79 ±0.21* 1.27 ± 0.17 1.12 ± 0.17*
Homocysteine (μmol/L) 9.95 ±2.81 9.17 ±2.31 11.1 ±2.53 10.0 ± 2.31
Data are expressed as means ± SD.
Statistical comparison (test t) was between consumers and non-consumers groups of normolipidemic and hypercholesterolemic individuals.
*p < 0.05.
# Normolipidemic: total cholesterol < 6.2 mmol/L.
##Hypercholesterolemic: total cholesterol ≥ 6.2 mmol/L.
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cholesterol (−11%), LDL-cholesterol (−18%), LDL/HDL
ratio (−12%), and apo B (−12%) in comparison to
normolipidemics without orange juice consumption
(p ≤ 0.05). Similarly, hyperlipidemic men who consumed
orange juice showed lower total cholesterol (−5%),
LDL-cholesterol (−12%), apo B (−12%) and LDL/HDL
ratio (−16%) in comparison to those without orange
juice consumption (p ≤ 0.05) (Table 3). Although we
did not investigate the family history of heart disease
in this study, the identification of the hypercholesterolemic
subjects showed the genetic heritage for heart disease in
this group of people. On the other hand, triglycerides,
HDL-cholesterol, apo A-I and homocysteine did not show
any difference between consumers and non-consumers of
orange juice (p > 0.05) (Table 3). All individuals had normal
homocysteine levels (IMx Metabolic – Homocysteine,
Abbott Laboratory).
Significant inverse correlations (data not showed)
were found between regular orange juice intake and
the following biochemical variables: total cholesterol
(r = −0.35, p < 0.001), LDL-cholesterol (r = −0.38, p < 0.001),
apo B (r = −0.30, p < 0.003) and LDL/HDL ratio (r = −0.24,
p < 0.02) in men and women with normal cholesterol levels.
Significant inverse correlations were also found between
regular orange juice intake and total cholesterol (r = −0.31,
p < 0.05), LDL-cholesterol (r = −0.39, p < 0.02) and apo B
(r = −0.31, p < 0.05) in men with high cholesterol
levels. An inverse correlation was found between men
with regular orange juice intake and homocysteine
levels (r = −0.20, p < 0.05), and homocysteine levels
and apo A-I (r = −0.30, p < 0.001), while a positive
correlation was found between homocysteine levels and
triglycerides (r = 0.17, p < 0.04).
Discussion
Recent studies have debated the nutritional risks and
benefits of the regular consumption of fruit juices related
to the increase of overweight and obesity [6,29-32]. There
are some suggestions that calorie-free or low food energy
content beverages (water, tea, coffee, low fat milk, skim
milk, soy beverages) and non-calorically sweetened
beverages, should be preferred to beverages with
some nutritional benefits, such as fruit and vegetable
juices, whole milk, alcoholic beverages and sports
drinks, to prevent weight gain [29,31]. However, others
have shown that consumption of pure fruit juices, without
added sweeteners, did not contribute to weight gain
[6,30,32], but protected against chronic diseases such as
coronary heart disease and some cancers [33] because of
the contribution of bioactive compounds, including
flavonoids and vitamins. The statement that the consump-
tion of orange juice contributes to the development of
weight gain and obesity was not confirmed in the presentstudy nor by a recent epidemiological study with children
[34], since orange juice consumption was not associated
with body weight, body fat, waist circumference, obesity or
physical activity in this study. The majority of the
consumers and non-consumers of orange juice showed
low physical activity with no statistical difference among
groups. So, we suggested that physical activity had no
influence on the singularities detected on the markers
of lipid metabolism or on the intake of vitamin C and
folate, which were influenced by the consumption of
orange juice.
Together with excess weight, visceral fat can promote
metabolic disorders, such as insulin resistance, dyslipidemias
and high blood pressure [22,35]. In our work, the
percentage abdominal obesity among orange juice
consumers did not differ from that of non-consumers.
A meta-analysis showed that high consumption of
fruits, juices and non-starchy vegetables may change
body composition, reflected in BMI and abdominal
obesity. Hence, consumption of these fresh foods may
not help to reduce weight and waist circumference,
but may help to delay or prevent their increase
[36,37]. Also, orange juice has high nutritional density
with low food energy content [38] in comparison with
other unfortified juices and beverages, and helps consumers
to meet the nutritional requirements of vitamin C, folate
and potassium [39]. Orange juice can be considered a safe
and protective energy source since it protects against
oxidative or inflammatory stress [36].
Most participants of the present study followed a simi-
lar diet, since they had the two main meals of the day,
breakfast and lunch, at the company’s restaurant from
Monday through Friday. According to the dietary recalls,
there was no difference among orange juice consumers
and non-consumers regarding dietary energy, protein,
carbohydrate, dietary fibers, total fruit, total fat, cholesterol,
and potassium consumption. Moreover, the orange juice
consumers showed significantly higher intake of vitamin C
and folate, attributable to their average orange juice intake
(480 mL/d). A previous experiment [18] verified a linear
increase of vitamin C in the blood serum with increasing
doses of orange juice, from 250 to 750 mL, while
serum folate concentration only increased significantly
when orange juice consumption reached 750 mL/d,
suggesting that folate bioavailability is limited by its
source and concentration in food.
Folate supplementation can decrease the homocysteine
of individuals with originally normal and high levels,
with dietary folate providing a beneficial impact on
homocysteine levels [40]. Orange juice is one of the most
common sources of folate in the human diet: 250 mL of
orange juice contains 47 μg of folate [41], which may help
to control serum homocysteine levels [18]. A mean orange
juice intake of 480 mL/d provides an increase in dietary
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those who consume 720 mL of orange juice. Most likely
these increased folate intakes were responsible for
the significant inverse correlation that was detected
in the present study between orange juice and serum
homocysteine levels, observed only for males.
The serum homocysteine levels of men with normal
and high cholesterol levels who consumed orange juice
daily did not differ significantly from those of their
respective counterparts who did not consume orange
juice daily. A previous study showed that consumption
of orange juice below 750 mL/d did not affect serum
homocysteine levels [18]. However, another author
observed that serum homocysteine levels only decreased
when daily folate intake reached 250 μg [42]. More
recently, a study found that daily intake of 250 to 500 μg
of folate reduced serum homocysteine levels by 11 to 20%
[42]. Dosages below 250 μg/d do not seem to affect serum
homocysteine levels significantly; nevertheless, orange
juice still contributes to the total daily folate intake.
The present study found an inverse correlation between
serum homocysteine levels and apo A-I, which is in agree-
ment with a recent study of patients with coronary artery
disease [42]. A positive correlation was also observed
between serum homocysteine levels and serum triglycerides
(r = 0.17, p < 0.04). A study in animals found a direct rela-
tionship between high homocysteine levels and changes in
lipid metabolism that increased the risk of coronary artery
disease [43]. Most participants, who consumed orange juice
regularly, showed a slight reduction in homocysteine levels,
that is, 8.5% in normolipidemic individuals and 11% in
hypercholesterolemic individuals, although not significantly.
High homocysteine levels in humans and animals are asso-
ciated with endothelial dysfunction, accumulation of fats in
the liver, low HDL- cholesterol and a slight change in total
cholesterol [42,44]. An experimental study using supra
physiological dosages of homocysteine found that the
underlying mechanism involves inhibition of apo A-I
synthesis in the liver and consequent reduction of serum
HDL- cholesterol and its functional and anti-inflammatory
activities on the endothelium [44].
The dietary intake of saturated fat and cholesterol
of the normolipidemic orange juice consumers or
non-consumers was close to the dietary guidelines of
American Heart Association [23]. On the other hand,
hypercholesterolemic subjects, both consumers and
non-consumers, had higher intake of dietary cholesterol
(> 300 mg/d), but the dietary saturated fat followed the
recommended allowance (< 7% of total food energy
intake). One of the strategies to reduce serum cholesterol
according to the AHA is to consume foods containing
stanol/sterol esters, such as orange juice fortified with
stanol ester, or foods high in bioactive compounds which
can improve the lipid profile [23].The present study found that orange juice consumers
had on average lower serum levels of total cholesterol
and LDL-cholesterol in comparison with non-consumers.
Presumably these effects are related to citrus flavonoid
compounds found in orange juice [5,43]. In vivo studies
have shown that naringenin and hesperitin inhibited
ACAT and microsomal transfer protein (MTP) activities,
which are responsible for the synthesis and esterification
of the cholesterol in the liver [16], resulting in lower Apo
B secretion and consequently lower LDL-cholesterol levels
[45]. Also a significant negative correlation was found
between orange juice consumption and total choles-
terol, LDL-cholesterol and LDL/HDL ratio in humans
[5,10,14,46]. These study results elucidate the beneficial
effect of orange juice on serum LDL-cholesterol levels in
agreement with in vivo studies that demonstrate an
effective cholesterol-lowering action of the bioactive
components of orange juice, such as flavanones and
vitamin C [5,10,14,46].
Additionally a previous study showed a positive effect
of orange juice on HDL-cholesterol levels with the
consumption of 750 mL of orange juice per day [18],
which was not verified in our study. Only 8% of our
volunteers (data not shown) had a daily orange juice
consumption that matched or exceeded the consumption
of 750 mL per day, which may account for the difference.
The average of apo B and LDL-cholesterol of the orange
juice consumers was lower in both normolipidemic and
hyperlipidemic groups. Furthermore, an inverse correlation
was found between regular orange juice consumption and
apo B, reinforcing the LDL-cholesterol lowering effect of
orange juice. An in vitro study found that hesperidin and
naringin reduced the availability of lipids for assembly of
apo B-containing lipoproteins: VLDL- and LDL-cholesterol,
which is attributed to reduced ACAT 1 and ACAT 2 activ-
ities, selective decrease in ACAT 2 expression and reduced
microsomal triglyceride transfer protein activity [16].
Serum triglyceride levels were statistically different
between consumers and non-consumers of orange juice,
despite the presence of sugars in the juice; however they
were higher in the hypercholesterolemic group than in
the normolipidemic. Animals given orange or grapefruit fla-
vanones daily experienced a reduction in serum triglyceride
levels [47] but studies with human beings have suggested
that the magnitude of their effect on triglyceride levels
depends primarily on other factors, such as age, gender,
fasting glucose, insulin and triglyceride levels, insulin
resistance and total fructose intake [36].
Although a smoking habit has been associated with a
significant increase of stroke, high blood pressure, and
damage to the arterial wall contributing to atherosclerosis,
all of them considered as risk factors for cardiovascular
disease [23], this behavior was not investigated in this
study. The main focus of this investigation were the
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orange juice on total cholesterol and LDL-cholesterol in
women and hyperlipidemic men, as previously detected
from these authors [13,14].
The first strength of this study was the volunteers have
been already exposed to daily orange juice consumption
and that they freely chose to consume or not. The second
strength of this study was the exposure of individuals to
the same main meals every day (breakfast and lunch). This
environment was more homogeneous than individuals
who had their meals at home or in different places.
Nevertheless, be exposed to the same food environment,
does not mean they ate the same foods. Therefore, the
assessment of food consumption was conducted through
the individual 24-hour recall. The limitation, however, was
that the dietary information was obtained through a self-
reported questionnaire, which may be subject to under or
over reporting and interviewer bias, and because of the
cross-sectional design, which is limited in verifying any
relationship between cause and effect.
Conclusions
This study suggested that long-term consumption of orange
juice by normolipidemic and hypercholesterolemic subjects
was not associated with weight or body fat, or plasma
triglyceride and homocysteine. It was, however, associated
with reduced total cholesterol, LDL-cholesterol, apo B and
LDL/HDL ratio. Hence, it corroborated the hypothesis that
long-term orange juice consumption was significantly
associated with favorable effects on risk factors for
cardiovascular disease, suggesting that future research
should test whether orange juice can be useful as a
secondary intervention in subjects with normal or
moderately high serum cholesterol.
Methods
Subjects and study design
It was a descriptive and cross-sectional study with
healthy volunteers who worked at Citrosuco (Fischer S/A –
Comercio Industria e Agricultura), an orange juice factory
located in Matao, SP, Brazil. A total of 129 volunteers
were selected to participate in this study, 103 men
aged 18 to 66 y and 26 women aged 18 to 65 y. None
of the 129 participants had thyroid, kidney, or heart disease,
diabetes, or required the use of pharmaceuticals, and those
who consumed more than zero but less than one cup of
orange juice per day (>0 or <240 mL/d) were excluded of
the sample as well. The study was approved by the Ethics
Committee of the School of Pharmaceutical Sciences, São
Paulo State University, and an informed written consent
was obtained from each participant.
General and anthropometric data were collected over
a four-week period by the researchers of this study.
During the first week of the experiment, blood sampleswere obtained from the median cubical vein and placed in
EDTA-containing vials. Serum samples were centrifuged
at 3,000 × g for 10 min at room temperature within 1 h of
collection and stored at −80°C until the assays of total
cholesterol, HDL-cholesterol, triglycerides, apoA1, apo B,
homocysteine, were performed at the Clinical Analyses
Laboratory, School of Pharmaceutical Sciences, UNESP,
Araraquara, SP. Reagents and instruments used for
these analyses are described on the Biochemical Tests
section.
Daily consumption of foods and beverages was deter-
mined with two 24-h recalls, described in “Dietary
assessment” section, conducted by the researchers
during four weeks of the experimental period. Nutritional
requirements were estimated according to the National
Research Council [28]. The frequency of the consumption
of orange juice was obtained with the first dietary recall
and all consumers stated that their primary source was
the orange juice from the company cafeteria. The specific
question addressed to the volunteers was: “How much
and how often did you drink orange juice during the last
12 months?” Those who reported drinking orange juice
every day, one to more cups per day, in the last twelve
months were selected as habitual consumers of orange
juice (n = 50), with an average intake of 480 ± 158 mL/d.
Those who did not drink orange juice during the last
twelve months (0 cup/d), as non-consumers (n = 79).
Those who consumed some orange juice, but less than
one cup per day (240 mL/d) were excluded of the sample.
All collected data were observational and descriptive of
the usual and spontaneous orange juice intake by the
volunteers.
Dietary, physical activity and anthropometric variables
of men and women were analyzed separately because of
the distinct gender characteristics for these variables.
Because dyslipidemias are under strong genetic influence,
the volunteers were divided into those with normal
cholesterol levels (n = 90, total cholesterol < 6.2 mmol/L)
and those with moderately high cholesterol levels (n = 39,
total cholesterol ≥ 6.2 mmol/L) in order to evaluate
the individual influence of orange juice on the blood
lipid profile.
Orange juice composition
Commercially processed orange juice (12° Brix, reconstituted
from concentrate) was provided daily in the company
restaurant as their primary source of orange juice as
reported by the volunteers. The average daily serving
of orange juice (480 mL) contained approximately
161 mg of vitamin C, 90 μg of folate, 851 mg of potas-
sium, 40 g of total sugar (19 g of sucrose, 10 g of glucose,
11 g of fructose) and 970 kJ (234 kcal) [48]. The flavonoid
content in 480 mL of orange juice was estimated at
26.4 mg of hesperitin and 7.4 mg of naringenin [48].
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Dietary assessment
Daily consumption of food and beverage was determined
by a 24-hour food recall and analyzed with a computer-
based data evaluation system (NUTRI software, version 2.5
CIS, Federal University of Sao Paulo School of Medicine,
Brazil). Food intakes were described in terms of portion
sizes, and sugar and lipid consumption was estimated from
the food preparation. Food energy intake was estimated
from the consumption of macronutrients in the 24-hour
food recall (Table 1), where 1 g of protein or carbohydrate
equals 16.7 kJ and 1 g of lipid equals 37.7 kJ. The
nutritional requirements of all individuals were estimated
according to the National Research Council [28].
Anthropometric and physical activity assessment
Body weight (kg) and height (m) were measured for all
volunteers and body mass index (BMI) was determined
(weight/height2) [49]. Waist circumference (narrowest
diameter between xiphoid process and iliac crest) was
measured in triplicate at one time for each subject, and
the average was taken as the final determination [50].
Bipolar body electrical bioimpedance was assessed early in
the morning to determine body fat, before the participants
had broken the overnight fast (Biodynamics Model 310e,
Seattle, WA, USA). An electric current of 0.8 mA and
50 kHz was produced by a calibrated signal generator and
applied to the skin using adhesive electrodes placed on
right-side limbs [50].
Physical activity was investigated with the first 24-h recall,
by four specific questions: practice or non-practice of phys-
ical activity, type of exercise, duration (h/d) and frequency
(times/wk). All these parameters were used to determinate
the physical activity coefficient (PA), which represents four
categories of life style, as sedentary, low active, active and
very active, according to gender and BMI [28].
Biochemical tests
Total serum cholesterol (CHOD-PAP; Roche), triacylglycerol
(Triglyceride Rapid; Roche), and HDL-cholesterol
(HDL Reagent Roche) were determined enzymatically
by an automated biochemical analyzer (Roche Cobas
e601, Switzerland). LDL-cholesterol was estimated by
Friedewald’s equation (1972) [51]. Apolipoprotein A (apo
A-I) and apolipoprotein B (apo B) were determined by
immunoturbidimetric assay using commercial kits (Roche
Diagnostics, Germany) in a Cobas MIRA analyzer (Roche,
Switzerland). Homocysteine (IMx Metabolic - Homocyst-
eine, Abbott Laboratory) was determined by the Axsym
system immunological method by fluorescence polarization
(AXSYM, Abbott, Wiesbaden, Germany).Statistical analyses
Sample size was calculated to detect means differences
with 90% power and 5% significance. Data were expressed
as mean ± standard deviation. The distribution of variables
was analyzed with Kolmogorov-Smirnov test. Variables
with normal distribution were analyzed with a Student’s
t-test. Non-parametric variables were analyzed with
the W-Wilcoxon test. Associations between orange
juice consumption and variables were analyzed using
a Spearman’s correlation. p-value of 0.05 was used to define
significance. The data were analyzed using Sigma Stat for
Windows® (version 3.11, 2004 Systat Software Inc, USA).
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